Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000221058

Medchemexpress LLC Methyl N-[[(5S)-3-[3-fluoro-4-(2-oxa-6-azaspiro[3.3]heptan-6-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl] | 2071265-08-0 | 99.7% | 365.36 g/mol | C17H20FN3O5 | 5 MG
SDP

Supplier:  Medchemexpress LLC HY1393985MG

Encompass_Preferred

TBI-223 is an orally active oxazolidinone antibiotic research compound investigated for activity against Mycobacterium tuberculosis and other bacterial pathogens. It has been evaluated in preclinical models and shows efficacy in mouse models of bloodstream, skin, and bone infections. The compound is provided for laboratory research in powder and DMSO solution formats.

  • Orally active oxazolidinone antibiotic.
  • Demonstrated activity against Mycobacterium tuberculosis in preclinical studies.
  • Efficacy shown in MRSA mouse models of bloodstream, skin, and bone infection.
  • High purity suitable for research applications (reported ~99.7%).
  • Available as solid powder and as DMSO solution for in vitro and in vivo studies.
  • Molecular formula C17H20FN3O5; molecular weight 365.36 g/mol.
  • Supplied for research use only; not for human therapeutic use.

Catalog No. 50-002-21058


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.